Onechip Bioelectronics is a biotechnology startup that specializes in innovative biosensor chip technology for genetic testing, water quality monitoring, and environmental protection. Founded in 2014, the company, operating under the name Wanzhong Yixin Biotechnology, is at the forefront of pioneering semiconductor integrated circuit biosensor chips and related devices. Targeting diverse industries including biotechnology, hardware, healthcare, information technology, and autonomous and sensor tech, Onechip's biosensor chip products have found applications in advanced fields. The latest milestone for the company includes a noteworthy CNY100.00M Series B investment from Chengdu Future Medical City Investment Fund and Dianke Venture Capital on 28 September 2023.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | CNY100.00M | 2 | Chengdu Future Medical City Investment Fund, Dianke Venture Capital | 28 Sep 2023 |
Series B | CNY150.00M | 6 | Xiamen C&D Emerging Industry Equity Investment, Zhiyun Yu +2 | 19 Apr 2022 |
Series B | CNY20.00M | 1 | 01 Feb 2018 | |
Series A | CNY10.00M | 1 | Chengdushi Panxin | 27 Apr 2017 |
Angel Round | CNY3.00M | - | 01 Mar 2016 |
No recent news or press coverage available for Onechip Bioelectronics.